NASDAQ: PRTG
Portage Biotech Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their PRTG stock forecasts and price targets.

Forecast return on equity

Is PRTG forecast to generate an efficient return?

Company
N/A
Industry
146.26%
Market
80.85%

Forecast return on assets

Is PRTG forecast to generate an efficient return on assets?

Company
N/A
Industry
36.38%

PRTG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PRTG$11.03N/AN/A
NERV$1.73$5.00+189.86%Hold
RLYB$0.30$5.00+1,544.74%Buy
IMNN$0.88$21.50+2,340.41%Strong Buy
ATHA$0.30N/AN/A

Portage Biotech Stock Forecast FAQ

What is PRTG's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: PRTG) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Portage Biotech stock.

What is PRTG's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: PRTG) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 36.38%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.